基本信息 产品详情 公司简介 推荐产品
网站主页 4'-甲氧基-3',5-二-2-丙烯基-(1,1'-联苯)-2-醇 4-O-甲基和厚朴酚
  • 4-O-甲基和厚朴酚 4-O-Methylhonokiol

4-O-甲基和厚朴酚 4-O-Methylhonokiol

4-O-methyl-honokiol
68592-15-4
询价 500瓶 起订
湖北 更新日期:2026-07-13

武汉恒和达生物医药有限公司

VIP14年
联系人:刘经理
电话:027-84888681拨打
手机:18086046872 拨打
邮箱:hhdpharm@hotmail.com

产品详情:

中文名称:
4-O-甲基和厚朴酚
英文名称:
4-O-methyl-honokiol
CAS号:
68592-15-4
纯度规格:
98%
产品类别:
novel chemicals
提取来源:
厚朴

Wuhan hengheda Pharm offers high quality 4-O-Methylhonokiol, 4-O-Methylhonokiol  is a naturally occurring lignan derived primarily from the bark and seeds of Magnolia officinalis and related species, which have been utilized in traditional medicine for centuries. Chemically, it is a methylated derivative of honokiol, characterized by the addition of a methoxy group (-OCH₃) at the 4-position of the biphenyl core structure. This modification enhances its lipophilic properties, potentially improving membrane permeability and bioavailability compared to its parent compound. With a molecular formula of C₂₁H₂₄O₂ and a molecular weight of 316.4 g/mol, 4-O-methylhonokiol exhibits structural similarities to other magnolia-derived bioactive compounds, such as honokiol and magnolol, yet demonstrates distinct pharmacological profiles due to its unique substitution pattern.

Extensive preclinical studies have highlighted 4-O-methylhonokiol’s multifaceted biological activities. It exhibits potent anti-inflammatory and antioxidant effects, primarily through the inhibition of NF-κB and MAPK signaling pathways, making it a candidate for treating chronic inflammatory conditions, including neurodegenerative diseases and metabolic disorders. Furthermore, its anxiolytic and neuroprotective properties—mediated via modulation of GABAergic systems and activation of Nrf2-mediated antioxidant responses—suggest therapeutic potential for anxiety, depression, and Alzheimer’s disease. Emerging evidence also points to anti-cancer activity, where it induces apoptosis and suppresses metastasis in various cancer cell lines by targeting PI3K/AKT and Wnt/β-catenin pathways. Additionally, its ability to improve insulin sensitivity and mitigate oxidative stress in metabolic models underscores its relevance in addressing obesity-linked complications. Despite promising preclinical data, further research is required to evaluate its pharmacokinetics, safety profile, and efficacy in clinical settings, paving the way for potential pharmaceutical or nutraceutical applications.


厚朴;厚朴酚;和厚朴酚;

公司简介

武汉恒和达生物医药有限公司成立于2013年,公司总部位于武汉经济技术开发区民营科技工业园,为湖北省高新技术企业,主要从事原料药、高端医药中间体和精细化工产品的研发与生产,以及新化合物的技术咨询和检测等服务。恒和达生物目前拥有1000平米的研发及中试平台,并配备了各种现代化的实验研究设备,满足了各种化合物的小试研究,中试放大的生产。合作生产基地占地30余亩,配备了成套大型不锈钢和搪玻璃生产设备,反应釜设备从50L到2000L不等,具有吨位级的研发生产能力。

成立日期 (14年)
注册资本 100万人民币元
员工人数 10-50人
年营业额 ¥ 500万-1000万
经营模式 贸易,工厂,定制,服务
主营行业 医药中间体,分子砌块,原料药,氨基酸及其衍生物

4-O-甲基和厚朴酚相关厂家报价

内容声明
拨打电话 立即询价